The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

CAPEOX v. FOLFOXIRI - comparisons?

bibliophile
bibliophile CSN Member Posts: 133 Member

I was diagnosed with T4bN1bG2M1 colon cancer with perineural involvement in 2023. RO colon surgery followed by 8 cycles of CAPEOX. Lung met that had remained stable during chemo but started growing again was removed this March because it appeared to be solitary, followed by a swift recovery. We are only 3 months later and a post-surgery CT shows new metastases to abdominal lymph node and peritoneal carcinomatosis (2 nodules). I am (relatively) young and very healthy with no symptoms right now, so they are throwing everything and the kitchen sink at this in hopes of still making me a candidate for CRS/HIPEC. So my questions are, first step is FOLFOXIRI starting July 1st. I tolerated the CAPEOX pretty well overall. Anyone done both CAPEOX and FOLFOXIRI and can tell me how much worse it's going to be this time around? They might add additional drugs or immunotherapies depending on the results of my tumor mutation typing when it comes back. Also, has anyone done the CRS/HIPEC and want to weigh in? Thanks so much. Having a hard time wrapping my brain around this.